- Home
- VRA vs ANVS Comparison
VRA vs ANVS Comparison
Compare VRA & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- ANVS
- Stock Information
- Founded
- VRA 1982
- ANVS 2008
- Country
- VRA United States
- ANVS United States
- Employees
- VRA N/A
- ANVS N/A
- Industry
- VRA Apparel
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- VRA Consumer Discretionary
- ANVS Health Care
- Exchange
- VRA Nasdaq
- ANVS Nasdaq
- Market Cap
- VRA 60.6M
- ANVS 55.5M
- IPO Year
- VRA 2010
- ANVS 2020
- Fundamental
- Price
- VRA $2.20
- ANVS $2.48
- Analyst Decision
- VRA Buy
- ANVS Strong Buy
- Analyst Count
- VRA 3
- ANVS 4
- Target Price
- VRA $3.05
- ANVS $17.33
- AVG Volume (30 Days)
- VRA 197.7K
- ANVS 210.1K
- Earning Date
- VRA 09-11-2025
- ANVS 11-07-2025
- Dividend Yield
- VRA N/A
- ANVS N/A
- EPS Growth
- VRA N/A
- ANVS N/A
- EPS
- VRA N/A
- ANVS N/A
- Revenue
- VRA $332,526,000.00
- ANVS N/A
- Revenue This Year
- VRA N/A
- ANVS N/A
- Revenue Next Year
- VRA $3.80
- ANVS N/A
- P/E Ratio
- VRA N/A
- ANVS N/A
- Revenue Growth
- VRA N/A
- ANVS N/A
- 52 Week Low
- VRA $1.71
- ANVS $1.11
- 52 Week High
- VRA $5.99
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- VRA 54.38
- ANVS 52.16
- Support Level
- VRA $1.94
- ANVS $2.26
- Resistance Level
- VRA $2.49
- ANVS $2.51
- Average True Range (ATR)
- VRA 0.15
- ANVS 0.12
- MACD
- VRA 0.02
- ANVS 0.02
- Stochastic Oscillator
- VRA 47.27
- ANVS 87.10
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.